Patent · US Active

Primarily niobium stent

US7604703B2 · kind B2 · utility

1Cited by
80References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 3, 2006
Grant dateOct 20, 2009
Priority date
Expiry dateJan 21, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61F2310/00598
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

In a process of fabricating a stent composed primarily of niobium alloyed with a trace amount of zirconium, tantalum, or titanium for hardening, the stent is annealed under vacuum in a substantially oxygen-free environment. The vacuum is preferably maintained at pressure less than 10−4 millibars, oxygen-content less than about 80 parts per million, and the annealing temperature exceeds 400° C. for at least one hour, and is preferably kept in a range from about 1100-1200° C. for several hours. This may be followed by applying a surface layer of oxide, such as iridium oxide, with a thickness of 299-300 nm to the stent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.